Comparison of PET–CT and contrast-enhanced CT in the evaluation of recurrent oral squamous cell carcinoma
International Journal of Oral and Maxillofacial Surgery · 2026-07 · 55 (7) · 743-746
DOI: 10.1016/j.ijom.2026.02.018 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Oral and Maxillofacial Surgery, 2026-07. Verfasst von R V Raja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of ENT and Head and Neck Surgery, Nandha Medical College and Hospital, Erode, Tamil Nadu, India. Electronic address: fantazrup11@gmail.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Mouth Neoplasms, Neoplasm Recurrence, Local, Tomography, X-Ray Computed. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Recurrence is common among patients with loco-regionally advanced oral cancer. This single-centre, retrospective study was performed to compare positron emission tomography-computed tomography (PET-CT) and conventional contrast-enhanced computed tomography (CECT) in evaluation of recurrent oral squamous cell carcinoma, following definitive treatment. Patients with suspected recurrence during 2016-2019 were included. CECT findings were reviewed by two consultants and PET-CT findings by one consultant. All reviewers were blinded to the assessments of others. Concordance between CECT and PET-CT was evaluated. 195 patients met the necessary criteria. Common primary subsites were buccal mucosa (36.4%) and tongue (30.8%). Majority patients had loco-regionally advanced disease (66.3%). Surgery alone was the primary modality of treatment (93.3%). Disease detection was similar among the two individual CECT raters and the PET-CT rater. For the PET-CT rater vs CECT raters combined, detection rate was 69.2% vs 71.8% for local disease, 47.7% vs 51.3% for regional disease, and 22.1% vs 21.5% for distant disease. Kappa values for inter-rater agreement ranged from 0.55 to 0.74 and were statistically significant (all P < 0.001 ), suggesting substantial agreement among the raters. This study revealed that CECT was comparable to PET-CT for detecting oral malignancy recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of ENT and Head and Neck Surgery, Nandha Medical College and Hospital, Erode, Tamil Nadu, India. Electronic address: fantazrup11@gmail.com.
- Department of Head and Neck Surgical Oncology, Tata Medical Centre, Newtown, Kolkata, India.
- Department of Nuclear Medicine, Tata Medical Centre, Newtown, Kolkata, India.
- Department of Radiology, Tata Medical Centre, Newtown, Kolkata, India.
Zitieren
APA
Raja, R. V., Manikantan, K., Jain, P. V., Arun, P., Das, J., Sen, S., & Gehani, A. (2026). Comparison of PET–CT and contrast-enhanced CT in the evaluation of recurrent oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 55(7), 743-746. https://doi.org/10.1016/j.ijom.2026.02.018
Vancouver
Raja RV, Manikantan K, Jain PV, Arun P, Das J, Sen S, et al. Comparison of PET–CT and contrast-enhanced CT in the evaluation of recurrent oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery. 2026;55(7):743-746. doi:10.1016/j.ijom.2026.02.018
BibTeX
@article{Raja2026,
author = {Raja, R V and Manikantan, K and Jain, P V and Arun, P and Das, J and Sen, S and Gehani, A},
title = {Comparison of PET–CT and contrast-enhanced CT in the evaluation of recurrent oral squamous cell carcinoma},
journal = {International Journal of Oral and Maxillofacial Surgery},
year = {2026},
volume = {55},
number = {7},
pages = {743--746},
doi = {10.1016/j.ijom.2026.02.018}
}
EUVIMED